|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
O’Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar
|
|
4
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
et al: Identification and expansion of human
colon-cancer-initiating cells. Nature. 445:111–115. 2007.
View Article : Google Scholar
|
|
5
|
Yeung TM and Mortensen NJ: Colorectal
cancer stem cells. Dis Colon Rectum. 52:1788–1796. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sugihara E and Saya H: Complexity of
cancer stem cells. Int J Cancer. 132:1249–1259. 2013. View Article : Google Scholar
|
|
7
|
Lou H and Dean M: Targeted therapy for
cancer stem cells: the patched pathway and ABC transporters.
Oncogene. 26:1357–1360. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sussman RT, Ricci MS, Hart LS, Sun SY and
El-Deiry WS: Chemotherapy-resistant side-population of colon cancer
cells has a higher sensitivity to TRAIL than the non-SP, a higher
expression of c-Myc and TRAIL-receptor DR4. Cancer Biol Ther.
6:1490–1495. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Todaro M, Alea MP, Di Stefano AB, et al:
Colon cancer stem cells dictate tumor growth and resist cell death
by production of interleukin-4. Cell Stem Cell. 1:389–402. 2007.
View Article : Google Scholar
|
|
10
|
Walko CM and Lindley C: Capecitabine: a
review. Clin Ther. 27:23–44. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kelland L: The resurgence of
platinum-based cancer chemotherapy. Nat Rev Cancer. 7:573–584.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wen K, Fu Z, Wu X, et al: Oct-4 is
required for an antiapoptotic behavior of chemoresistant colorectal
cancer cells enriched for cancer stem cells: effects associated
with STAT3/Survivin. Cancer Lett. 333:56–65. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Holland JD, Klaus A, Garratt AN and
Birchmeier W: Wnt signaling in stem and cancer stem cells. Curr
Opin Cell Biol. 25:254–264. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pannuti A, Foreman K, Rizzo P, et al:
Targeting Notch to target cancer stem cells. Clin Cancer Res.
16:3141–3152. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Takebe N, Harris PJ, Warren RQ and Ivy SP:
Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog
pathways. Nat Rev Clin Oncol. 8:97–106. 2011. View Article : Google Scholar
|
|
16
|
Lee J, Kotliarova S, Kotliarov Y, et al:
Tumor stem cells derived from glioblastomas cultured in bFGF and
EGF more closely mirror the phenotype and genotype of primary
tumors than do serum-cultured cell lines. Cancer Cell. 9:391–403.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Singh SK, Clarke ID, Terasaki M, et al:
Identification of a cancer stem cell in human brain tumors. Cancer
Res. 63:5821–5828. 2003.PubMed/NCBI
|
|
18
|
Liu JC, Deng T, Lehal RS, Kim J and
Zacksenhaus E: Identification of tumorsphere- and tumor-initiating
cells in HER2/Neu-induced mammary tumors. Cancer Res. 67:8671–8681.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vlashi E, Kim K, Lagadec C, et al: In vivo
imaging, tracking, and targeting of cancer stem cells. J Natl
Cancer Inst. 101:350–359. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang AD, Fan F, Camp ER, et al: Chronic
oxaliplatin resistance induces epithelial-to-mesenchymal transition
in colorectal cancer cell lines. Clin Cancer Res. 12:4147–4153.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dallas NA, Xia L, Fan F, et al:
Chemoresistant colorectal cancer cells, the cancer stem cell
phenotype, and increased sensitivity to insulin-like growth
factor-I receptor inhibition. Cancer Res. 69:1951–1957. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chu ZH, Liu L, Zheng CX, et al: Proteomic
analysis identifies translationally controlled tumor protein as a
mediator of phosphatase of regenerating liver-3-promoted
proliferation, migration and invasion in human colon cancer cells.
Chin Med J (Engl). 124:3778–3785. 2011.
|
|
23
|
Vaiopoulos AG, Kostakis ID, Koutsilieris M
and Papavassiliou AG: Colorectal cancer stem cells. Stem Cells.
30:363–371. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Marin JJ, Sanchez de Medina F, Castaño B,
et al: Chemoprevention, chemotherapy, and chemoresistance in
colorectal cancer. Drug Metab Rev. 44:148–172. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Puglisi MA, Tesori V, Lattanzi W,
Gasbarrini GB and Gasbarrini A: Colon cancer stem cells:
controversies and perspectives. World J Gastroenterol.
19:2997–3006. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tirino V, Desiderio V, Paino F, et al:
Cancer stem cells in solid tumors: an overview and new approaches
for their isolation and characterization. FASEB J. 27:13–24. 2013.
View Article : Google Scholar
|
|
27
|
Yu Y, Kanwar SS, Patel BB, et al:
Elimination of colon cancer stem-like cells by the combination of
curcumin and FOLFOX. Transl Oncol. 2:321–328. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bose D, Zimmerman LJ, Pierobon M, et al:
Chemoresistant colorectal cancer cells and cancer stem cells
mediate growth and survival of bystander cells. Br J Cancer.
105:1759–1767. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yeung TM, Gandhi SC and Bodmer WF: Hypoxia
and lineage specification of cell line-derived colorectal cancer
stem cells. Proc Natl Acad Sci USA. 108:4382–4387. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Koch U and Radtke F: Notch and cancer: a
double-edged sword. Cell Mol Life Sci. 64:2746–2762. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Qiao L and Wong BC: Role of notch
signaling in colorectal cancer. Carcinogenesis. 30:1979–1986. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Arcaroli JJ, Powell RW, Varella-Garcia M,
et al: ALDH+ tumor-initiating cells exhibiting gain in NOTCH1 gene
copy number have enhanced regrowth sensitivity to a γ-secretase
inhibitor and irinotecan in colorectal cancer. Mol Oncol.
6:370–381. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang Y, Li B, Ji ZZ and Zheng PS: Notch1
regulates the growth of human colon cancers. Cancer. 116:5207–5218.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jin HY, Zhang HY, Wang X, Xu J and Ding Y:
Expression and clinical significance of notch signaling genes in
colorectal cancer. Tumour Biol. 33:817–824. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Meng RD, Shelton CC, Li YM, et al:
gamma-Secretase inhibitors abrogate oxaliplatin-induced activation
of the Notch-1 signaling pathway in colon cancer cells resulting in
enhanced chemosensitivity. Cancer Res. 69:573–582. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
McAuliffe SM, Morgan SL, Wyant GA, et al:
Targeting Notch, a key pathway for ovarian cancer stem cells,
sensitizes tumors to platinum therapy. Proc Natl Acad Sci USA.
109:E2939–E2948. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ponnurangam S, Mammen JM, Ramalingam S, et
al: Honokiol in combination with radiation targets notch signaling
to inhibit colon cancer stem cells. Mol Cancer Ther. 11:963–972.
2012. View Article : Google Scholar : PubMed/NCBI
|
